BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18473812)

  • 1. Targeting protein kinase C (PKC) in physiology and cancer of the gastric cell system.
    Fährmann M
    Curr Med Chem; 2008; 15(12):1175-91. PubMed ID: 18473812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer.
    Carter CA
    Curr Drug Targets; 2000 Sep; 1(2):163-83. PubMed ID: 11465069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular distribution of gastric chief cell protein kinase C activity: differential effects of diacylglycerol, phorbol esters, carbachol, and cholecystokinin.
    Raffaniello RD; Raufman JP
    J Cell Biochem; 1992 Jan; 48(1):107-13. PubMed ID: 1583072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C: a worthwhile target for anticancer drugs?
    Caponigro F; French RC; Kaye SB
    Anticancer Drugs; 1997 Jan; 8(1):26-33. PubMed ID: 9147607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C: a novel target for inhibiting gastric cancer cell invasion.
    Schwartz GK; Jiang J; Kelsen D; Albino AP
    J Natl Cancer Inst; 1993 Mar; 85(5):402-7. PubMed ID: 8433394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
    Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
    Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high throughput system for the evaluation of protein kinase C inhibitors based on Elk1 transcriptional activation in human astrocytoma cells.
    Sharif TR; Sharif M
    Int J Oncol; 1999 Feb; 14(2):327-35. PubMed ID: 9917510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C inhibitors as novel anticancer drugs.
    Goekjian PG; Jirousek MR
    Expert Opin Investig Drugs; 2001 Dec; 10(12):2117-40. PubMed ID: 11772309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoskeletal PKC and ERK/MAPK activation in response to N-nitrosamines and phorbol 12-myristate 13-acetate in gastric adenocarcinoma cells.
    Atten MJ; Attar BM; Holian O
    Anticancer Res; 1998; 18(6A):4377-82. PubMed ID: 9891495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibition of protein kinase C activity could induce apoptosis in gastric cancer cells by differential regulation of apoptosis-related genes.
    Zhu GH; Wong BC; Eggo MC; Yuen ST; Lai KC; Lam SK
    Dig Dis Sci; 1999 Oct; 44(10):2020-6. PubMed ID: 10548353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C-alpha attenuates cholinergically stimulated gastric acid secretion of rabbit parietal cells.
    Fährmann M; Kaufhold M; Pfeiffer AF; Seidler U
    Br J Pharmacol; 2003 Jun; 139(3):545-54. PubMed ID: 12788814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
    Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
    Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alteration of subcellular distribution of protein kinase C isoforms in swelling-activated multi-drug-resistant gastric cancer cells and its significance].
    Han Y; Shi Y; Zhang H
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(6):328-31. PubMed ID: 11798893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classical PKC isoforms in cancer.
    Martiny-Baron G; Fabbro D
    Pharmacol Res; 2007 Jun; 55(6):477-86. PubMed ID: 17548205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Helicobacter pylori fatty acid cis-9,10-methyleneoctadecanoic acid stimulates protein kinase C and increases DNA synthesis of gastric HM02 cells.
    Beil W; Obst B; Wagner S; Sewing KF
    Br J Cancer; 1998 Jun; 77(11):1852-6. PubMed ID: 9667658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha.
    Basu A
    Mol Pharmacol; 1998 Jan; 53(1):105-11. PubMed ID: 9443937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C activity in human gastric carcinoma.
    Uchida N; Okamura S; Kuwano H
    Oncol Rep; 2000; 7(4):793-6. PubMed ID: 10854546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression.
    Isakov N
    Semin Cancer Biol; 2018 Feb; 48():36-52. PubMed ID: 28571764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling.
    Jarvis WD; Fornari FA; Tombes RM; Erukulla RK; Bittman R; Schwartz GK; Dent P; Grant S
    Mol Pharmacol; 1998 Nov; 54(5):844-56. PubMed ID: 9804619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical development.
    Kaubisch A; Schwartz GK
    Cancer J; 2000; 6(4):192-212. PubMed ID: 11038138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.